How Does Diagnostic Accuracy Evolve with Increased Breast MRI Experience?

Author:

Wu Tong1,Alikhassi Afsaneh1ORCID,Curpen Belinda1ORCID

Affiliation:

1. Breast Imaging Division, Medical Imaging Department, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada

Abstract

Introduction: Our institution is part of a provincial program providing annual breast MRI screenings to high-risk women. We assessed how MRI experience, background parenchymal enhancement (BPE), and the amount of fibroglandular tissue (FGT) affect the biopsy-proven predictive value (PPV3) and accuracy for detecting suspicious MRI findings. Methods: From all high-risk screening breast MRIs conducted between 1 July 2011 and 30 June 2020, we reviewed all BI-RADS 4/5 observations with pathological tissue diagnoses. Overall and annual PPV3s were computed. Radiologists with fewer than ten observations were excluded from performance analyses. PPV3s were computed for each radiologist. We assessed how MRI experience, BPE, and FGT impacted diagnostic accuracy using logistic regression analyses, defining positive cases as malignancies alone (definition A) or malignant or high-risk lesions (definition B). Findings: There were 536 BI-RADS 4/5 observations with tissue diagnoses, including 77 malignant and 51 high-risk lesions. A total of 516 observations were included in the radiologist performance analyses. The average radiologist’s PPV3 was 16 ± 6% (definition A) and 25 ± 8% (definition B). MRI experience in years correlated significantly with positive cases (definition B, OR = 1.05, p = 0.03), independent of BPE or FGT. Diagnostic accuracy improved exponentially with increased MRI experience (definition B, OR of 1.27 and 1.61 for 5 and 10 years, respectively, p = 0.03 for both). Lower levels of BPE significantly correlated with increased odds of findings being malignant, independent of FGT and MRI experience. Summary: More extensive MRI reading experience improves radiologists’ diagnostic accuracy for high-risk or malignant lesions, even in MRI studies with increased BPE.

Publisher

MDPI AG

Subject

Radiology, Nuclear Medicine and imaging

Reference27 articles.

1. Canadian Cancer Statistics (2023, May 14). A 2022 Special Report on Cancer Prevalence. Canadian Cancer Society. Available online: http://cancer.ca/Canadian-Cancer-Statistics-2022-EN.

2. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers;Kuchenbaecker;JAMA,2017

3. Breast Cancer Facts & Figure 2022, Figure 2023 and Figure 2024 (2023, May 14). American Cancer Society. Available online: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/2022-2024-breast-cancer-fact-figures-acs.pdf.

4. Breast Cancer Screening for Women at High Risk–Cancer Care Ontario (2023, May 14). Cancer Care Ontario n.d. Available online: https://www.cancercareontario.ca/en/guidelines-advice/cancer-continuum/screening/breast-cancer-high-risk-women.

5. D’Orsi, C.J., Sickles, E.A., Mendelson, E.B., and Morris, E.A. (2013). ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System, American College of Radiology.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3